Immunosuppressive drugs have been used in transplant surgery units for over 20 years. It was soon found that azathioprine on its own failed to prevent rejection even in kidney transplants from living related donors.' A combination of azathioprine and steroids was therefore adopted, the steroids being given in high doses initially and then "tapered" over the ensuing weeks. As cortisone on its own had been shown to be ineffective in prolonging the survival of kidney transplants in dogs,2 the evidence on which this protocol was based is difficult to discover in retrospect. Goodwin et al had reported a definite improvement in renal function in a patient with a renal transplant whose rejection was treated with large doses of prednisone,3 so a period of treatment with high doses of steroids immediately after transplantation seemed a sensible approach, since rejection was very likely to occur at that time. For the next 14 years this immunosuppressive protocol was unchallenged. High doses of steroids were administered prophylactically, despite the fact that rejection was seldom suppressed altogether and that side effects were inevitable.
In 1977 McGeown et al reported that excellent survival of transplanted kidneys could be obtained with azathioprine and a daily maintenance dose of steroids of just 20 mg (0.3 mg kg).4
This dose was chosen in the belief that the wellbeing of the patient was far more important than that of the transplant, but at that time there was no experimental evidence to point to the likely outcome. Fortunately this approach was a success and it has since been supported by experimental and clinical studies which have shown that survival of the graft is not jeopardised by lowering the dose of steroids.
In rats a low dose of steroids (0.5 mg/kg a day) has been found to be just as effective as a high maintenance dose (4 mg kg a day) when given with azathioprine to animals with a heterotopic heart graft.5 The same has been shown in baboons, the higher dose (2 mg,'kg a day) merely serving to increase the number of wound infections. 6 Three controlled clinical trials comparing low and high dose tapered regimens of steroids have now been carried out in Britain in patients receiving cadaveric renal transplants. In Oxford7 the starting daily doses were 30 mg and 100 mg respectively. In Cardiff the dose was 25 or 150 mg a day,8 and in a trial in Birmingham9 the equivalent groups received 20 mg and 75 mg a day. All patients received azathioprine in addition, and in the Oxford trial the low dose group was given 1 g of methylprednisolone intravenously on days 6, 7, and 8 Cyclosporin A has been under trial in transplant centres for nearly five years, and its general introduction is now imminent. The early trials on patients given renal transplants showed that a combination of cyclosporin and conventional treatment caused overimmunosuppression and the appearance of lymphomas.32 This has also been found in monkeys with cardiac transplants.33 Unfortunately, in human cardiac transplantation cyclosporin does not appear to be sufficiently immunosuppressive on its own to suppress rejection, and some sort of combination drug treatment is required. This again has resulted in some patients developing lymphomas,34 but cyclosporin and a low dose of prednisolone may provide a satisfactory compromise.35 Although such a combination is no more immunosuppressive in dogs than cyclosporin alone,36 this regimen has been adopted by a number of centres performing clinical renal transplantation, particularly in the United States. In Europe the emphasis has been on using cyclosporin on its own, and in a controlled clinical trial carried out in eight European renal transplant centres the patients given cyclosporin did better than did the control group treated with azathioprine and steroids.37 Rejection was quite often a problem, however, and ultimately 730 ofthe patients required steroids at one time or another. Assuming that steroids are needed with cyclosporin (and this has still to be shown in a controlled clinical trial) then the precise dose will need to be established soon to avoid some potentially toxic regimen being adopted as a world standard. The regimen that has been used so successfully by Starzl et a138 had a starting steroid dose of 200 mg, which was decreased daily to a maintenance dose of 20 mg a day by the sixth day after transplantation. Though this "tapered" regimen was not overtly toxic it may have been unnecessary-for reasons already discussed.
The immunosuppressive protocols using high doses of steroids that have been popular in the last two decades have undoubtedly been responsible for much of the considerable morbidity and mortality that have accompanied transplantation. Many transplant units have now changed to low dose regimens, with no evidence to date that survival of grafts has suffered as a consequence. Though steroids may still be needed in combination with cyclosporin, the minimum effective dose must be found from controlled studies before an unnecessarily high dose is adopted as a standard for the future.
Chronic headaches in general practice
In one week a busy general practitioner may see between 10 and 20 patients complaining of headaches-a total of 500 to 1000 a year. If he is worried that each one may have a cerebral tumour he will have a lot of worried patients. The fear of missing a primary cerebral neoplasm is unnecessary, however, because these tumours are rare-2500 a year in the whole of Britain. In an average practice of 3000 to 4000 patients one such tumour should be seen in five to 10 years. Furthermore, a brain tumour replaces normal tissue and gives rise to progressive neurological deficit or epilepsy, or both; headache alone is uncommon. "A headache of more than one year's duration without physical signs is not due to a structural lesion" is a useful aphorism of the late Sir Charles Symonds, a great neurologist with a vast clinical experience and a mammoth memory. Beware of the headache that has changed in character, however; it then becomes a new and recent headache.
How, then, does one tackle the common problem of chronic Tension headache is a continuous symmetrical headache, often described as a pressure, an awareness, or discomfort at the vertex, forehead, occiput, in a coronal distribution, or all over the head, and not associated with visual or gastrointestinal disturbances. The ache occurs daily, lasts many hours, frequently throughout the waking period, rarely interfering with everyday activities, and is unaffected by analgesics but may respond to sedatives. Typically the patient complains of "a band round my head as if I am wearing a hat," or "a pressure, like a weight on top of my head."
Muscle contraction headache is a painful tender muscle or muscle spasm adjacent to a painful site-for example, cervical spondylosis, an impacted wisdom tooth, or the temporomandibular joint. The pain is accentuated by movement of the muscle and often relieved by heat, cold, or analgesics. Treating the underlying cause gives partial or complete relief of symptoms.
Difficulties arise with a mixture of two or three of these common headaches. Then the doctor has to analyse each headache in turn, which may take 15-20 minutes-not possible during a busy evening surgery and a special appointment may be necessary. In a recent series of 100 patients referred to two neurologists interested in headaches and migraine, 53 had migraine alone; 26 had migraine and tension or muscle contraction headache; 16 had tension or muscle contraction headaches, or both; three had migrainous neuralgia (cluster headache); and two were not diagnosed at the initial consultation.4 But these were difficult cases, often undergoing their second referral for consultant opinion.
The importance of making the right diagnosis is to determine the line of treatment. Tension headache as defined above is usually due to anxiety, depression, or agitated depression and requires treatment along psychiatric lines. Muscle contraction pain is helped by a dental surgeon, a physiotherapist, or other appropriate physical treatment. The management of migraine has recently been outlined. 3 How does the busy general practitioner cope with these chronic headaches ? Most cases can be diagnosed in three to four minutes of history taking. Although I have described 15 questions of pain analysis,5 the spontaneous remarks by the patient, followed by a few direct questions about timing,
